1. O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes
   Steffi F. Baldini et al, 2016, Front. Oncol. CrossRef
2. Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
   Nuzhat Ahmed et al, 2016, Sci Rep CrossRef
3. Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.
   Girolamo Ranieri, 0 CrossRef
4. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis
   Kyung Ha Lee et al, 2017 CrossRef
5. Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism
   Tatsuo Kanda et al, 2017 CrossRef
6. Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition
   Daniel K. Glatzel et al, 2018, J. Lipid Res. CrossRef
7. Aberrant high expression level of MORC2 is a common character in multiple cancers
   Ding Qian-shan et al, 2018, Human Pathology CrossRef
8. Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes
   Li-Chiung Lin et al, 2017, Cancer Letters CrossRef
9. Nickel inhibits mitochondrial fatty acid oxidation
   Radha Uppala et al, 2015, Biochemical and Biophysical Research Communications CrossRef
10. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis
    Yi Wang et al, 2015, Biochemical and Biophysical Research Communications CrossRef
11. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.
    Lin Wang et al, 2018, Biochim Biophys Acta Gen Subj CrossRef
12. GlycineN-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates
    Curtis C. Hughey et al, 2018, J. Biol. Chem. CrossRef
13. Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade
    Zhenpeng Qiu et al, 2018, Molecular Carcinogenesis CrossRef
14. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
    Serena De Matteis et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
15. Antitumor effects of curcumin: A lipid perspective
    Mehri Bemani Naeini et al, 2019, J Cell Physiol CrossRef
16. Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells
    Candace Miethe et al, 2019 CrossRef
17. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
    Johanna DiStefano et al, 2019, Cancers CrossRef
18. AKT and ERK dual inhibitors: The way forward?
    Zhe Cao et al, 2019, Cancer Lett CrossRef
19. AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis
    Qianshan Ding et al, 2016, J Clin Pathol CrossRef
20. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters
    Josiane Elia et al, 2019, Lipids Health Dis CrossRef
21. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats
    Geraldine Harriman et al, 2016, Proc Natl Acad Sci USA CrossRef
22. Diagnostic Challenges of Kidney Cancer: A Systematic Review of the Role of Positron Emission Tomography-Computerized Tomography
    Ofer N. Gofrit et al, 2016, Journal of Urology CrossRef
23. TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers
    Katharina Leithner et al, 2016, PLoS ONE CrossRef
24. Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
    R. Ariel Igal, 2016, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
25. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma
    Jianfeng Wang et al, 2016, PLoS ONE CrossRef
26. Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells
    Jessica E. C. Jones et al, 2017, PLoS ONE CrossRef
27. Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis
    Rajni Kumari et al, 2019, Nat Commun CrossRef
28. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor
    Satoru Nishizawa et al, 2017, European Journal of Pharmacology CrossRef
29. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma
    Pei-song Bai et al, 2017, J. Cell. Mol. Med. CrossRef
30. Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition
    Akito Ono et al, 2017, PLoS ONE CrossRef
31. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
    Shoeb Ikhlas et al, 2017, Life Sci CrossRef
32. Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling
    Hye-Youn Kim et al, 2017, Sci Rep CrossRef
33. LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer
    Yi Yu et al, 2019, Future Oncology CrossRef
34. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis
    Liu Yunxin et al, 2019, Biochemical Pharmacology CrossRef
35. Stearoyl-CoA Desaturase-1 Enzyme Inhibition by Grape Skin Extracts Affects Membrane Fluidity in Human Colon Cancer Cell Lines
    Valeria Tutino et al, 2020, Nutrients CrossRef
36. Structural characterization of human O-phosphoethanolamine phospho-lyase
    Chiara Vettraino et al, 2020, Acta Crystallogr F Struct Biol Commun CrossRef
37. Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy
    Advait Shetty et al, 2020, ACS Omega CrossRef
38. A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
    Li Yang et al, 2016, Oncotarget CrossRef
39. The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells
    Javier A. Menendez et al, 2016, Oncoscience CrossRef
40. A saturated fatty acid-rich diet enhances steatogenesis and liver tumorigenesis in HCV core gene transgenic mice
    Pan Diao et al, 2020, The Journal of Nutritional Biochemistry CrossRef
41. Silencing of ECHDC1 inhibits growth of gemcitabine‑resistant bladder cancer cells
    Seiji Asai et al, 2017, Oncol Lett CrossRef
42. Insulin and Metformin Control Cell Proliferation by Regulating TDG-Mediated DNA Demethylation in Liver and Breast Cancer Cells
    Jia-Bao Yan et al, 2020, Molecular Therapy - Oncolytics CrossRef
43. Leveraging a gain-of-function allele of Caenorhabditis elegans paqr-1 to elucidate membrane homeostasis by PAQR proteins
    Kiran Busayavalasa et al, 2020, PLoS Genet CrossRef
44. GCN5 acetyltransferase in cellular energetic and metabolic processes
    Beste Mutlu et al, 2020, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
45. Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer
    Mohamed Amine Lounis et al, 2020, Cancers CrossRef
46. Autophagy activation and SREBP‐1 induction contribute to fatty acid metabolic reprogramming by leptin in breast cancer cells
    Duc‐Vinh Pham et al, 2020, Mol Oncol CrossRef
47. Diospyros kaki and Citrus unshiu Mixture Improves Disorders of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
    Mi-Rae Shin et al, 2020, Canadian Journal of Gastroenterology and Hepatology CrossRef
48. Reticular Whitish Gray Lesions of the Oral Mucosa with No Habit History: A Critical Appraisal
    Archana Gupta et al, 2018 CrossRef
49. Lipid Metabolism—An Aberrant Shift in Cancer: A Narrative Review
    Samudrala V Sowmya et al, 2018 CrossRef
50. Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
    Jialei Weng et al, 2021, JHC CrossRef
51. miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell
    Ao Wang et al, 2021 CrossRef
52. Paradigm shift: the primary function of the “Adiponectin Receptors” is to regulate cell membrane composition
    Marc Pilon, 2021, Lipids Health Dis CrossRef
53. Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation
    Arthur Cassio de Lima Luna et al, 2021, Mol Cell Biochem CrossRef
54. Fatty acid synthesis and prostate cancer
    Tomas Koltai et al, 2021 CrossRef
55. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
    Marko Hojnik et al, 2021, Cancers CrossRef
56. Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
    Yi Zhou et al, 2022, Semin Liver Dis CrossRef
57. Biguanides drugs: Past success stories and promising future for drug discovery
    Oleksandr Grytsai et al, 2021, European Journal of Medicinal Chemistry CrossRef
58. Lipid Catabolism and ROS in Cancer: A Bidirectional Liaison
    Serena Castelli et al, 2021, Cancers CrossRef
59. Lipid metabolism reprogramming in renal cell carcinoma
    Gioia Heravi et al, 2021, Cancer Metastasis Rev CrossRef
60. Stearoyl-CoA desaturase 1 inhibitor supplemented with gemcitabine treatment reduces the viability and fatty acid content of pancreatic cancer cells in vitro
    Amon B. Hackney et al, 2021 CrossRef
61. Metabolic response to radiation therapy in cancer
    Graham H. Read et al, 2021, Molecular Carcinogenesis CrossRef
62. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
    Shanmugam Murugaiha Jeyakumar et al, 2022, WJH CrossRef
63. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
    Marko Hojnik et al, 2022, Cancers CrossRef
64. Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs
    Maria Malvina Tsamouri et al, 2022, Metabolites CrossRef
65. Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
    Yu-Ting Tsai et al, 2022, J Biomed Sci CrossRef
66. Alpinumisoflavone Exhibits the Therapeutic Effect on Prostate Cancer Cells by Repressing AR and Co-Targeting FASN- and HMGCR-Mediated Lipid and Cholesterol Biosynthesis
    Praveenkumar Basavaraj et al, 2022, Life CrossRef
67. A review on the role of fatty acids in colorectal cancer progression
    Malvina Hoxha et al, 2022, Front. Pharmacol. CrossRef
68. The intersection between Wnt signaling pathway and cancer metabolism
    Wenzhu Liu, 2022 CrossRef
69. Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer
    Matthew Alberto et al, 2023, Cancers CrossRef
70. Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
    Yi Zhang et al, 2023, Biomolecules CrossRef
71. Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy
    Davide Gnocchi et al, 2023, IJMS CrossRef
72. The differential role of resistin on invasive liver cancer cells
    Candace Miethe et al, 2023 CrossRef
73. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery.
    Nicola Antonio di Meo et al, 2023, Expert Rev Mol Diagn CrossRef
74. Prostate Cancer: Advances in Genetic Testing and Clinical Implications
    Ahmad S. Abdelrazek et al, 2023, Uro CrossRef
75. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies
    Dimitri Vanauberg et al, 2023, Oncogenesis CrossRef
76. Metabolic protein kinase signalling in neuroblastoma
    William J. Smiles et al, 2023, Molecular Metabolism CrossRef
77. Targeting dysregulated lipid metabolism in the tumor microenvironment
    Do-Hee Kim et al, 2023, Arch. Pharm. Res. CrossRef
78. Association of saturated fatty acids with cancer risk: a systematic review and meta-analysis
    Jin Mei et al, 2024, Lipids Health Dis CrossRef
79. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer
    Jianqing Qiu et al, 2024, Cancer Biology & Therapy CrossRef
80. The m6A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN
    Tao Jiang et al, 2024, Mol Cancer CrossRef
81. Metabolic adaptations in prostate cancer
    Mikel Pujana-Vaquerizo et al, 2024, Br J Cancer CrossRef
82. Aging AdipoR2‐deficient mice are hyperactive with enlarged brains excessively rich in saturated fatty acids
    Mario Ruiz et al, 2024, The FASEB Journal CrossRef
83. [Retracted] Nanoemulsion and Encapsulation Strategy of Hydrophobic Oregano Essential Oil Increased Human Prostate Cancer Cell Death via Apoptosis by Attenuating Lipid Metabolism
    Haribalan Perumalsamy et al, 2022, Bioinorganic Chemistry and Applications CrossRef
84. Tumour growth inhibitory effect of Ibervillea sonorae phytopreparations in cervical cancer xenografts
    Max Vidal-Gutiérrez et al, 2024, Natural Product Research CrossRef
85. Altered metabolism in cancer: insights into energy pathways and therapeutic targets
    Muhammad Tufail et al, 2024, Mol Cancer CrossRef
86. Altered Metabolites in Hepatocellular Carcinoma (HCC) Paving the Road for Metabolomics Signature and Biomarkers for Early Diagnosis of HCC
    Hiba S Al-Amodi et al, 2024 CrossRef
87. Application of 1H NMR Metabolic Profiling of Serum in Canine Multicentric Lymphoma
    Rosina Sánchez Solé et al, 2024, Vet Comparative Oncology CrossRef